De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
LivaNova Inkomsten in het verleden
Verleden criteriumcontroles 0/6
LivaNova is de winst gegroeid met een gemiddeld jaarlijks percentage van 33.5%, terwijl de Medical Equipment industrie de winst jaarlijks groeide met 11.5%. De inkomsten zijn gegroeid met een gemiddelde van 2.2% per jaar.
Belangrijke informatie
33.5%
Groei van de winst
34.8%
Groei van de winst per aandeel
| Medical Equipment Groei van de industrie | 8.9% |
| Inkomstengroei | 2.2% |
| Rendement op eigen vermogen | -1.3% |
| Nettomarge | -1.4% |
| Volgende winstupdate | 30 Oct 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Are Investors Undervaluing LivaNova PLC (NASDAQ:LIVN) By 31%?
Oct 02
LivaNova PLC's (NASDAQ:LIVN) Prospects Need A Boost To Lift Shares
Aug 21LivaNova (NASDAQ:LIVN) Might Have The Makings Of A Multi-Bagger
Jul 30At US$52.79, Is It Time To Put LivaNova PLC (NASDAQ:LIVN) On Your Watch List?
Jul 04Is LivaNova PLC (NASDAQ:LIVN) Trading At A 31% Discount?
Jun 13LivaNova: Focus Is Paying Off
May 12These Return Metrics Don't Make LivaNova (NASDAQ:LIVN) Look Too Strong
Apr 08Is It Time To Consider Buying LivaNova PLC (NASDAQ:LIVN)?
Feb 05A Look At The Intrinsic Value Of LivaNova PLC (NASDAQ:LIVN)
Jan 15LivaNova PLC's (NASDAQ:LIVN) Business And Shares Still Trailing The Industry
Dec 25LivaNova (NASDAQ:LIVN) Could Be At Risk Of Shrinking As A Company
Nov 29We Think LivaNova's (NASDAQ:LIVN) Profit Is Only A Baseline For What They Can Achieve
Nov 08At US$47.94, Is LivaNova PLC (NASDAQ:LIVN) Worth Looking At Closely?
Oct 16Are Investors Undervaluing LivaNova PLC (NASDAQ:LIVN) By 44%?
Sep 25Capital Allocation Trends At LivaNova (NASDAQ:LIVN) Aren't Ideal
Jul 26Should You Investigate LivaNova PLC (NASDAQ:LIVN) At US$51.43?
Jul 03An Intrinsic Calculation For LivaNova PLC (NASDAQ:LIVN) Suggests It's 37% Undervalued
Jun 09Investors Could Be Concerned With LivaNova's (NASDAQ:LIVN) Returns On Capital
Apr 13What Does LivaNova PLC's (NASDAQ:LIVN) Share Price Indicate?
Mar 13Estimating The Fair Value Of LivaNova PLC (NASDAQ:LIVN)
Feb 15Returns At LivaNova (NASDAQ:LIVN) Are On The Way Up
Nov 25Is There Now An Opportunity In LivaNova PLC (NASDAQ:LIVN)?
Oct 29LivaNova Loses Profit Momentum On Higher R&D Expense
Oct 13LivaNova PLC (NASDAQ:LIVN) Shares Could Be 30% Below Their Intrinsic Value Estimate
Oct 11FDA labels recall of blood bypass pump systems by LivaNova as most serious
Sep 30Returns On Capital At LivaNova (NASDAQ:LIVN) Have Hit The Brakes
Aug 09LivaNova PLC Non-GAAP EPS of $0.53 beats by $0.01, revenue of $254.2M beats by $4.65M, lowers FY earning guidance
Aug 03Is There Now An Opportunity In LivaNova PLC (NASDAQ:LIVN)?
Jul 19A Look At The Fair Value Of LivaNova PLC (NASDAQ:LIVN)
Jun 27LivaNova Matures Into Profitability, Still Waiting On DTD
May 10Opbrengsten en kosten
Hoe LivaNova geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 1,210 | -17 | 527 | 178 |
| 31 Mar 24 | 1,185 | -32 | 524 | 184 |
| 31 Dec 23 | 1,154 | 18 | 518 | 188 |
| 30 Sep 23 | 1,118 | 3 | 499 | 212 |
| 30 Jun 23 | 1,085 | -97 | 479 | 201 |
| 31 Mar 23 | 1,045 | -82 | 470 | 184 |
| 31 Dec 22 | 1,022 | -86 | 464 | 175 |
| 30 Sep 22 | 1,017 | -93 | 474 | 146 |
| 30 Jun 22 | 1,018 | -29 | 468 | 152 |
| 31 Mar 22 | 1,028 | -102 | 475 | 171 |
| 31 Dec 21 | 1,035 | -136 | 472 | 183 |
| 30 Sep 21 | 1,035 | -414 | 462 | 191 |
| 30 Jun 21 | 1,022 | -385 | 457 | 197 |
| 31 Mar 21 | 939 | -417 | 442 | 169 |
| 31 Dec 20 | 934 | -347 | 447 | 153 |
| 30 Sep 20 | 952 | -208 | 462 | 147 |
| 30 Jun 20 | 981 | -161 | 481 | 146 |
| 31 Mar 20 | 1,076 | -102 | 501 | 155 |
| 31 Dec 19 | 1,084 | -158 | 528 | 147 |
| 30 Sep 19 | 1,094 | -222 | 495 | 162 |
| 30 Jun 19 | 1,097 | -260 | 489 | 159 |
| 31 Mar 19 | 1,107 | -211 | 484 | 159 |
| 31 Dec 18 | 1,107 | -178 | 465 | 146 |
| 30 Sep 18 | 1,088 | 0 | 444 | 135 |
| 30 Jun 18 | 1,068 | 33 | 424 | 121 |
| 31 Mar 18 | 1,036 | 59 | 397 | 115 |
| 31 Dec 17 | 1,012 | 54 | 380 | 110 |
| 30 Sep 17 | 795 | 121 | 292 | 66 |
| 30 Jun 17 | 840 | 92 | 303 | 69 |
| 31 Mar 17 | 905 | 55 | 329 | 71 |
| 31 Dec 16 | 965 | 2 | 355 | 82 |
| 31 Dec 15 | 545 | -22 | 221 | 63 |
| 18 Oct 15 | 295 | 14 | 136 | 44 |
| 24 Jul 15 | 301 | 57 | 124 | 41 |
| 24 Apr 15 | 292 | 58 | 124 | 42 |
| 23 Jan 15 | 292 | 66 | 126 | 44 |
| 24 Oct 14 | 288 | 63 | 124 | 44 |
| 25 Jul 14 | 285 | 60 | 124 | 45 |
| 25 Apr 14 | 282 | 55 | 121 | 45 |
| 24 Jan 14 | 276 | 48 | 118 | 46 |
| 25 Oct 13 | 270 | 47 | 116 | 45 |
Kwaliteitswinsten: LIVN is momenteel verliesgevend.
Groeiende winstmarge: LIVN is momenteel verliesgevend.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: LIVN is verlieslatend, maar heeft de verliezen de afgelopen 5 jaar met een snelheid van 33.5% per jaar verminderd.
Versnelling van de groei: Het is niet mogelijk om de winstgroei van LIVN over het afgelopen jaar te vergelijken met het gemiddelde over de afgelopen vijf jaar, omdat het bedrijf momenteel verliesgevend is.
Winst versus industrie: LIVN is verlieslatend, waardoor het lastig is om de winstgroei van het afgelopen jaar te vergelijken met die van de Medical Equipment industrie ( 7.9% ).
Rendement op eigen vermogen
Hoge ROE: LIVN heeft een negatief Return on Equity ( -1.34% ), omdat het momenteel verliesgevend is.